Clinical Supply, FDA and Protein Expression

Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions

Rapid delivery of toxicological material

Drug Target Review

SEPTEMBER 10, 2024

In our experience, reaching a rapid drug substance material delivery to support toxicology studies is becoming a major milestone on the Phase I CMC clinical development path (Figure 1). Therefore, there would be almost no appetite for trying to justify a change in formulation between Tox and clinical supplies.

Drug Development

Drug Development Clinical Supply Production FDA

Drug Discovery Digest

Rapid delivery of toxicological material

Stay Connected